Di-cyclopropyl based IL-17A modulators and uses thereof
The disclosure herein provides compounds and pharmaceutical compositions of Formula (I) and Formula (I-A) for the modulation of IL-17A. Compounds and pharmaceutical compositions of Formula (I) and Formula (I-A) are useful for the treatment of inflammatory conditions, such as psoriasis.
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
01.12.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The disclosure herein provides compounds and pharmaceutical compositions of Formula (I) and Formula (I-A) for the modulation of IL-17A. Compounds and pharmaceutical compositions of Formula (I) and Formula (I-A) are useful for the treatment of inflammatory conditions, such as psoriasis. |
---|---|
Bibliography: | Application Number: TW20230106593 |